Meissner to Build New US$250 million Manufacturing Facility in USA
Introduction:
Meissner Corporation has recently announced its investment of US$250 million in the construction of a new manufacturing facility in Athens-Clarke County, Georgia, USA.
Features:
The development of this state-of-the-art facility is expected to create approximately 1,700 job opportunities over the next eight years, contributing significantly to the local economy.
The chosen location for Meissner's facility is 1310 Spring Valley Road in Winterville, situated within the Christian Industrial Tract.
With its diverse product range, Meissner plays a vital role in enabling the development and production of essential medications in therapeutic areas such as oncology, cardiology, and immunology.
This expansion project will greatly enhance the company's production capabilities in the United States, surpassing its current footprint. Once all planned phases are completed, the campus in Athens-Clarke County will more than double the size of Meissner's existing facilities.
The new site will boast a range of modern structures, including cutting-edge cleanroom facilities, laboratories, research and development areas, and office spaces.
These facilities will be instrumental in supporting Meissner's ongoing research and manufacturing efforts. Operations at the new building are scheduled to commence in early 2026.
Specifications:
|
Name |
Meissner |
|
Type |
Construction |
|
Budget |
US$250 million |
|
Year |
2026 |
